In an effort to reduce the number of people who become hospital patients, Hadassah-University Medical Center is now offering residents of Jerusalem newly infected with coronavirus an infusion of monoclonal antibodies. antigens, including viruses – became well known last year when former US President Donald Trump received him immediately after being diagnosed with COVID-19. Trump received the Regeneron antibody cocktail, which was approved by the FDA in November. He proclaimed the treatment as a “cure”. “I entered. I didn’t feel well. 24 hours later, I was feeling great, “said Trump in a video he posted on October 7.” I want everyone to receive the same treatment as their president because I feel great. ” Hadassah is administering a similar cocktail, Bamlanivimab, developed by the American company Eli Lilly, which was also approved by the FDA last November. Bamlanivimab is specifically targeted against the peak protein of SARS-CoV-2 and designed to block the binding of viruses and entry into a person’s cells. Hadassah’s program is aimed at newly diagnosed patients at high risk of developing a severe case of COVID, such as those who are using immunosuppressive drugs, receiving chemotherapy or dialysis, or who have had an organ transplant or lung disease. It is also available to anyone positive for coronavirus over 65 years.
cnxps.cmd.push (function () {cnxps ({playerId: ’36af7c51-0caf-4741-9824-2c941fc6c17b’}). render (‘4c4d856e0e6f4e3d808bbc1715e132f6’);});
if (window.location.pathname.indexOf (“656089”)! = -1) {console.log (“hedva connatix”); document.getElementsByClassName (“divConnatix”)[0].style.display = “none”;}“It is extremely important to inform people that they can change the natural course of this disease,” Hadassah director-general Zeev Rotstein told The Jerusalem Post. “Even before your symptoms start, they should come. We don’t want to miss a single day. ”Patients must arrive at Hadassah by ambulance to ensure that they do not infect anyone on the way. The treatment lasts about three hours, including observation. Then they return to their homes. So far, about a dozen patients have taken advantage of the program, which started last week and is being run in collaboration with health funds and the Ministry of Health, Rotstein said. As noted, antibodies are administered by infusion. Hadassah is the first Israeli hospital to offer this outpatient program. Despite the high level of vaccination in Israel, there are still many new cases a day, said Rotstein, adding: “We can save lives with this”.